Download the Protocol

Gonadorelin

Gonadorelin is a synthetic version of the natural hormone GnRH, which signals the body to release reproductive hormones. It helps regulate testosterone, estrogen, and fertility cycles. Researchers study it to understand how the brain communicates with the reproductive system and how hormonal balance can be restored or controlled.

Description

• Gonadorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) produced in the hypothalamus.
• Used in research to study regulation of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.
• Clinically utilized to test pituitary function and reproductive hormone response.

How It Works

• Stimulates GnRH receptors in the anterior pituitary, promoting LH and FSH secretion.
• Supports testosterone production in males and ovulation in females through the gonadal axis.
• Short half-life (~2–4 minutes) enables precise pulsatile dosing in experimental setups.

Documented Effects

• Increases circulating LH and FSH levels in both sexes.
• Restores spermatogenesis or ovulation under controlled pulsatile administration.
• Improves reproductive hormone synchronization in hypothalamic dysfunction research.

Theoretical Effects

• Potential applications in fertility restoration and hormonal rhythm modulation research.
• May help maintain natural gonadotropin cycles during long-term experimental studies.
• Human therapeutic use remains limited to controlled medical supervision.

Pharmacokinetics

• Half-life: ~2–4 minutes (rapid clearance from plasma).
• Time to peak effect: within 5–15 minutes after injection.
• Duration of action: approximately 1–2 hours through secondary LH/FSH release.

Duration of Effects

• Short hormonal pulse following administration; LH/FSH peaks quickly then declines.
• Requires repeated or pulsatile delivery to sustain physiological mimicry.
• Supports restoration of natural hormonal rhythms in long-term models.

Reconstitution

• Use only bacteriostatic water to reconstitute the lyophilized powder.
• Example vial: 2 mg of Gonadorelin
• Choose reconstitution volume based on dosing needs:
  • 1 mL → 2 mg/mL → 200 mcg per 10 units
  • 2 mL → 1 mg/mL → 100 mcg per 10 units
• Swirl gently to dissolve; do not shake.
• Refrigerate reconstituted solution (2–8 °C). Use within ~21 days for best stability.

Injectable Dosage Overview (Research Use)

Typical Starting Dose

• 100–250 mcg subcutaneous (SC) or intramuscular (IM) once daily.
• Conservative start: 100 mcg to gauge hormone response and tolerance.

Common Research Range

• 100–500 mcg per injection, 1–2× daily.
• Pulsatile dosing every 60–120 minutes mimics physiological GnRH release patterns.

Maximum Research Range

• Up to 1 mg daily, split into multiple administrations.
• Excessive frequency may cause receptor desensitization and reduced gonadotropin output.

Standard Cycle Length

• Short-term studies: 2–4 weeks for axis stimulation or evaluation.
• Extended protocols (6–8 weeks) used for reproductive recovery or hormonal studies.

Combination Research

• May be paired with hCG or FSH analogs to study synergistic hormonal responses.
• Useful for assessing pituitary and gonadal interaction under different stimulus intervals.

Clinical Notes

• Stimulates LH and FSH release; most effective when administered in short, physiologic pulses.
• Administer subcutaneously or intramuscularly; rotate injection sites to minimize irritation.
• Dosing on an empty stomach may slightly enhance pituitary responsiveness.
• Transient flushing, warmth, or mild headache can occur due to acute LH/FSH surge.
• Avoid continuous high-dose use, as sustained exposure can lead to pituitary desensitization.
• Stable for about 21 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes (First-Time Use)

• Possible mild flushing, headache, or abdominal discomfort shortly after injection.
• Overuse can suppress gonadotropin activity through receptor downregulation.
• Research compound only; not approved for unsupervised or self-administration.